TY - JOUR
T1 - Medical Malpractice in Uveitis
T2 - A Review of Clinical Entities and Outcomes
AU - Reddy, Ashvini K.
AU - Engelhard, Stephanie B.
AU - Shah, Christopher T.
AU - Sim, Austin J.
AU - Thorne, Jennifer E.
N1 - Publisher Copyright:
© Taylor & Francis Group, LLC.
PY - 2018/2/17
Y1 - 2018/2/17
N2 - Purpose: To guide risk management in uveitis. Methods: Retrospective review of malpractice verdicts, rulings, and settlements. Results: The WestLaw® database was reviewed for lawsuits related to uveitis in the United States from 1930–2014. Twenty-five cases met inclusion criteria, and 48% of these were infectious. Overall, 64% of outcomes favored the defendant ophthalmologist. The most common diagnoses were viral retinitis (28%), iritis (12%), syphilis (8%), and toxoplasmosis (8%). Seven suits (28%) were resolved by settlement, with mean adjusted indemnities of $724,302 (median, $409,390; range, $127,837–2,021,887). Two cases (8%) resulted in plaintiff verdict, with adjusted awards of $1,399,800 and $630,799. Conclusions: Despite being a rare diagnosis, viral retinitis (especially acute retinal necrosis) is the most common clinical entity associated with litigation in uveitis and should be considered early. Educating patients about potential adverse events, early testing for syphilis, and maintaining a positive relationship may also minimize risk.
AB - Purpose: To guide risk management in uveitis. Methods: Retrospective review of malpractice verdicts, rulings, and settlements. Results: The WestLaw® database was reviewed for lawsuits related to uveitis in the United States from 1930–2014. Twenty-five cases met inclusion criteria, and 48% of these were infectious. Overall, 64% of outcomes favored the defendant ophthalmologist. The most common diagnoses were viral retinitis (28%), iritis (12%), syphilis (8%), and toxoplasmosis (8%). Seven suits (28%) were resolved by settlement, with mean adjusted indemnities of $724,302 (median, $409,390; range, $127,837–2,021,887). Two cases (8%) resulted in plaintiff verdict, with adjusted awards of $1,399,800 and $630,799. Conclusions: Despite being a rare diagnosis, viral retinitis (especially acute retinal necrosis) is the most common clinical entity associated with litigation in uveitis and should be considered early. Educating patients about potential adverse events, early testing for syphilis, and maintaining a positive relationship may also minimize risk.
KW - Acute retinal necrosis
KW - litigation
KW - malpractice
KW - uveitis
UR - http://www.scopus.com/inward/record.url?scp=84981513421&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84981513421&partnerID=8YFLogxK
U2 - 10.1080/09273948.2016.1202289
DO - 10.1080/09273948.2016.1202289
M3 - Article
C2 - 27715388
AN - SCOPUS:84981513421
SN - 0927-3948
VL - 26
SP - 242
EP - 248
JO - Ocular Immunology and Inflammation
JF - Ocular Immunology and Inflammation
IS - 2
ER -